Correlation Between Bank of America and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Bank of America and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Bank of America and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Sinphar Pharmaceutical.
Diversification Opportunities for Bank of America and Sinphar Pharmaceutical
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bank and Sinphar is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Bank of America i.e., Bank of America and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between Bank of America and Sinphar Pharmaceutical
Considering the 90-day investment horizon Bank of America is expected to generate 4.1 times more return on investment than Sinphar Pharmaceutical. However, Bank of America is 4.1 times more volatile than Sinphar Pharmaceutical Co. It trades about 0.22 of its potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.03 per unit of risk. If you would invest 4,265 in Bank of America on August 25, 2024 and sell it today you would earn a total of 435.00 from holding Bank of America or generate 10.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Bank of America vs. Sinphar Pharmaceutical Co
Performance |
| Timeline |
| Bank of America |
| Sinphar Pharmaceutical |
Bank of America and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Sinphar Pharmaceutical
The main advantage of trading using opposite Bank of America and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.| Bank of America vs. Toronto Dominion Bank | Bank of America vs. Nu Holdings | Bank of America vs. HSBC Holdings PLC | Bank of America vs. Bank of Montreal |
| Sinphar Pharmaceutical vs. CHC Healthcare Group | Sinphar Pharmaceutical vs. GenMont Biotech | Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. Wellell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |